Dr. Andy Hwang brings over 15 years of experience in clinical operations and drug development, with a focus on early-phase oncology and immunology programs. He currently serves as Vice President of Clinical Operations at AVEO Oncology, an LG Chem company. Dr. Hwang most recently served as Vice President of Clinical Operations at Sail Biomedicines, where
Danielle Holland serves as Senior Vice President, General Counsel and Corporate Secretary of AVEO Oncology, an LG Chem company. Prior to joining AVEO, Ms. Holland served as an Associate at Skadden, Arps, Slate, Meagher & Flom LLP where she advised public and private clients in a variety of industries in corporate and securities law matters, mergers
Karam Hijji serves as the VP, Legal at AVEO Oncology, an LG Chem company, and is an experienced legal professional with a strong background in intellectual property and corporate law. He began his career at the U.S. Patent and Trademark Office as a patent examiner in the chemical arts, where he served for seven years.
Barbara Fielman has more than 25 years of experience in the pharmaceutical industry, and rejoins AVEO Oncology, an LG Chem company, as Senior Vice President of Clinical Operations and Medical Science Liaisons. Ms. Fielman most recent experiences include her leading the clinical operations teams at Hookipa Pharma, Inc. and Sumitomo Pharma America (formerly Sumitomo Pharma
Mike Ferraresso serves as Chief Commercial Officer of AVEO Oncology, an LG Chem company. He has over 25 years of commercial pharmaceutical and biotechnology experience, including advancing five biotech companies into commercial organizations through first product launches. At AVEO, in addition to developing the company’s commercial strategy and infrastructure, Mr. Ferraresso serves on the Executive
Bob Fedak serves as the Vice President of Information Technology at AVEO Oncology, an LG Chem company. With an Information Technology career spanning over 20 years, Mr. Fedak brings his extensive experience in building and leading highly engaged information technology teams, while ensuring a company’s information technology contributes to a positive work experience for all
Reetu Dandora serves as Vice President, Quality & Regulatory Compliance at AVEO Oncology, an LG Chem company. In this capacity, she provides executive leadership for AVEO’s GxP quality and regulatory compliance functions, ensuring robust governance across all aspects of the business. Ms. Dandora oversees inspection readiness, quality management systems, risk management programs, and the development
David Crist brings more than twenty years of oncology sales experience in both launch-stage and late-stage companies, building commercial organizations and developing high performing sales force teams. During his career, Mr. Crist held oncology-focused sales roles at several leading pharmaceutical companies including MGI (Molecular Genetics, Inc), Eisai, Sanofi Genzyme, GlaxoSmithKline and ARIAD Pharmaceuticals, where he
Dr. Edgar Braendle serves as Chief Medical Officer of AVEO Oncology, an LG Chem company. Dr. Braendle is a life sciences executive bringing over 20 years of experience spanning from early drug discovery to the launch of small molecules, biologics, radiopharmaceuticals, gene and cell therapies, and medical device development. Dr. Braendle most recently served as
Michael P. Bailey serves as president and chief executive officer for AVEO Oncology, an LG Chem company, and has been a member of AVEO’s board of directors since 2015 and currently serves as a CEO mentor for the Termeer Foundation. Michael brings more than 30 years of experience in the pharmaceutical industry to the company